The Economic Impact of Patent Law in Pharmaceutical Industry: Issue, Challenges and Benefits

Authors

  • Dr. Sushma Singh Associate Professor, Sharda University, Greater Noida, Uttar Pradesh, India Author
  • Neetu Jain Ph.D. Scholar, Sharda University, Greater Noida, Uttar Pradesh, India Author

Keywords:

IP Policy, IPRs, Patient Access, Pharmaceutical Industry, incentives

Abstract

The pharmaceutical industry occupies an unusually prominent position in discussions of IP policy and has been at the center of both domestic and international disputes over the interplay between IPRs, R&D incentives, price, and patient access. Despite the fervour of debate surrounding some key issues, there is comparatively little actual data to guide policy-making. This article reviews the empirical literature on intellectual property and pharmaceuticals, analyses methodological issues and important data sources, and outlines some of the most important research questions and knowledge gaps.

Downloads

Download data is not yet available.

Downloads

Published

09-02-2023

How to Cite

The Economic Impact of Patent Law in Pharmaceutical Industry: Issue, Challenges and Benefits. (2023). Asia Pacific Law & Policy Review, 9, 93-125. https://journal.thelawbrigade.com/aplpr/article/view/268

Similar Articles

11-20 of 51

You may also start an advanced similarity search for this article.